Somanetics Corp (NASDAQ:SMTS)

CAPS Rating: 4 out of 5

Develops, manufactures and markets the INVOS Cerebral Oximeter, the only non-invasive patient monitoring system commercially available in the United States that continuously measures changes in the blood oxygen level in the adult brain.

Recs

1
Player Avatar Wsteh (< 20) Submitted: 4/9/2009 12:16:26 AM : Outperform Start Price: $13.96 SMTS Score: +21.29

Strong moat. Net cash 40% of market cap. Expanding market application.

Featured Broker Partners


Advertisement